Literature DB >> 17561090

Platelet-associated NAD(P)H oxidase contributes to the thrombogenic phenotype induced by hypercholesterolemia.

Karen Y Stokes1, Janice M Russell, Merilyn H Jennings, J Steven Alexander, D Neil Granger.   

Abstract

Elevated cholesterol levels promote proinflammatory and prothrombogenic responses in venules and impaired endothelium-dependent arteriolar dilation. Although NAD(P)H oxidase-derived superoxide has been implicated in the altered vascular responses to hypercholesterolemia, it remains unclear whether this oxidative pathway mediates the associated arteriolar dysfunction and platelet adhesion in venules. Platelet and leukocyte adhesion in cremasteric postcapillary venules and arteriolar dilation responses to acetylcholine were monitored in wild-type (WT), Cu,Zn-superoxide dismutase transgenic (SOD-TgN), and NAD(P)H oxidase-knockout (gp91(phox-/-)) mice placed on a normal (ND) or high-cholesterol (HC) diet for 2 weeks. HC elicited increased platelet and leukocyte adhesion in WT mice versus ND. Cytosolic subunits of NAD(P)H oxidase (p47phox and p67phox) were expressed in platelets. This was not altered by hypercholesterolemia; however, platelets and leukocytes from HC mice exhibited elevated generation of reactive oxygen species compared to ND mice. Hypercholesterolemia-induced leukocyte recruitment was attenuated in SOD-TgN-HC and gp91(phox-/-)-HC mice. Recruitment of platelets derived from WT-HC mice in venules of SOD-TgN-HC or gp91(phox-/-)-HC recipients was comparable to ND levels. Adhesion of SOD-TgN-HC platelets paralleled the leukocyte response and was attenuated in SOD-TgN-HC recipients, but not in WT-HC recipients. However, gp91(phox-/-)-HC platelets exhibited low levels of adhesion comparable to those of WT-ND in both hypercholesterolemic gp91(phox-/-) and WT recipients. Arteriolar dysfunction was evident in WT-HC mice, compared to WT-ND. Overexpression of SOD or, to a lesser extent, gp91(phox) deficiency restored arteriolar vasorelaxation responses toward WT-ND levels. These findings reveal a novel role for platelet-associated NAD(P)H oxidase in producing the thrombogenic phenotype in hypercholesterolemia and demonstrate that NAD(P)H oxidase-derived superoxide mediates the HC-induced arteriolar dysfunction.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17561090      PMCID: PMC1975956          DOI: 10.1016/j.freeradbiomed.2007.02.027

Source DB:  PubMed          Journal:  Free Radic Biol Med        ISSN: 0891-5849            Impact factor:   7.376


  41 in total

1.  NAD(P)H oxidase-derived superoxide mediates hypercholesterolemia-induced leukocyte-endothelial cell adhesion.

Authors:  K Y Stokes; E C Clanton; J M Russell; C R Ross; D N Granger
Journal:  Circ Res       Date:  2001-03-16       Impact factor: 17.367

2.  Increased NADH-oxidase-mediated superoxide production in the early stages of atherosclerosis: evidence for involvement of the renin-angiotensin system.

Authors:  A Warnholtz; G Nickenig; E Schulz; R Macharzina; J H Bräsen; M Skatchkov; T Heitzer; J P Stasch; K K Griendling; D G Harrison; M Böhm; T Meinertz; T Münzel
Journal:  Circulation       Date:  1999-04-20       Impact factor: 29.690

3.  Angiotensin II attenuates endothelium-dependent responses in the cerebral microcirculation through nox-2-derived radicals.

Authors:  Helene Girouard; Laibaik Park; Josef Anrather; Ping Zhou; Costantino Iadecola
Journal:  Arterioscler Thromb Vasc Biol       Date:  2006-01-26       Impact factor: 8.311

4.  Role of platelets in hypercholesterolemia-induced leukocyte recruitment and arteriolar dysfunction.

Authors:  Karen Y Stokes; LeShanna Calahan; Janice M Russell; Shelly Gurwara; D Neil Granger
Journal:  Microcirculation       Date:  2006 Jul-Aug       Impact factor: 2.628

5.  Superoxide excess in hypertension and aging: a common cause of endothelial dysfunction.

Authors:  C A Hamilton; M J Brosnan; M McIntyre; D Graham; A F Dominiczak
Journal:  Hypertension       Date:  2001-02       Impact factor: 10.190

6.  Vascular superoxide production by NAD(P)H oxidase: association with endothelial dysfunction and clinical risk factors.

Authors:  T J Guzik; N E West; E Black; D McDonald; C Ratnatunga; R Pillai; K M Channon
Journal:  Circ Res       Date:  2000-05-12       Impact factor: 17.367

7.  Role of blood cell-associated AT1 receptors in the microvascular responses to hypercholesterolemia.

Authors:  Thomas Petnehazy; Karen Y Stokes; Katherine C Wood; Janice Russell; D Neil Granger
Journal:  Arterioscler Thromb Vasc Biol       Date:  2005-10-27       Impact factor: 8.311

8.  Angiotensin II type-1 receptor antagonism attenuates the inflammatory and thrombogenic responses to hypercholesterolemia in venules.

Authors:  Thomas Petnehazy; Karen Y Stokes; Janice M Russell; D Neil Granger
Journal:  Hypertension       Date:  2005-01-17       Impact factor: 10.190

9.  CD40 ligand influences platelet release of reactive oxygen intermediates.

Authors:  Subrata Chakrabarti; Sonia Varghese; Olga Vitseva; Kahraman Tanriverdi; Jane E Freedman
Journal:  Arterioscler Thromb Vasc Biol       Date:  2005-09-01       Impact factor: 8.311

10.  Penicillamine administration reverses the inhibitory effect of hyperhomocysteinaemia on endothelium-dependent relaxation and superoxide formation in the aorta of the rabbit.

Authors:  Nilima Shukla; Anthony Koupparis; Robert A W Jones; Gianni D Angelini; Raj Persad; Jamie Y Jeremy
Journal:  Eur J Pharmacol       Date:  2006-01-31       Impact factor: 4.432

View more
  17 in total

Review 1.  Role of blood cells in ischaemia-reperfusion induced endothelial barrier failure.

Authors:  Stephen F Rodrigues; D Neil Granger
Journal:  Cardiovasc Res       Date:  2010-03-17       Impact factor: 10.787

Review 2.  Effects of P2Y12 receptor antagonists beyond platelet inhibition--comparison of ticagrelor with thienopyridines.

Authors:  Sven Nylander; Rainer Schulz
Journal:  Br J Pharmacol       Date:  2016-02-24       Impact factor: 8.739

3.  NAD(P)H oxidase and eNOS play differential roles in cytomegalovirus infection-induced microvascular dysfunction.

Authors:  Igor L Leskov; Jennifer Whitsett; Jeannette Vasquez-Vivar; Karen Y Stokes
Journal:  Free Radic Biol Med       Date:  2011-10-06       Impact factor: 7.376

Review 4.  Microvascular responses to cardiovascular risk factors.

Authors:  D Neil Granger; Stephen F Rodrigues; Alper Yildirim; Elena Y Senchenkova
Journal:  Microcirculation       Date:  2010-04       Impact factor: 2.628

5.  Ischemia/reperfusion injury: The role of immune cells.

Authors:  Mozow Y Zuidema; Cuihua Zhang
Journal:  World J Cardiol       Date:  2010-10-26

6.  P-selectin mediates the microvascular dysfunction associated with persistent cytomegalovirus infection in normocholesterolemic and hypercholesterolemic mice.

Authors:  Evgeny Senchenkov; Mikhail V Khoretonenko; Igor L Leskov; Dmitry V Ostanin; Karen Y Stokes
Journal:  Microcirculation       Date:  2011-08       Impact factor: 2.628

7.  Hypercholesterolemia and microvascular dysfunction: interventional strategies.

Authors:  Phoebe A Stapleton; Adam G Goodwill; Milinda E James; Robert W Brock; Jefferson C Frisbee
Journal:  J Inflamm (Lond)       Date:  2010-11-18       Impact factor: 4.981

8.  The novel NOX inhibitor 2-acetylphenothiazine impairs collagen-dependent thrombus formation in a GPVI-dependent manner.

Authors:  D Vara; M Campanella; G Pula
Journal:  Br J Pharmacol       Date:  2013-01       Impact factor: 8.739

9.  HIV-1 antiretrovirals induce oxidant injury and increase intima-media thickness in an atherogenic mouse model.

Authors:  Bo Jiang; Valeria Y Hebert; Alok R Khandelwal; Karen Y Stokes; Tammy R Dugas
Journal:  Toxicol Lett       Date:  2009-03-09       Impact factor: 4.372

Review 10.  Oxidative risk for atherothrombotic cardiovascular disease.

Authors:  Jane A Leopold; Joseph Loscalzo
Journal:  Free Radic Biol Med       Date:  2009-09-12       Impact factor: 7.376

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.